Dr Stephanie Lael Stauffer, MD | |
200 Hawkins Dr, Department Of Pathology, Iowa City, IA 52242-1009 | |
(319) 356-1616 | |
Not Available |
Full Name | Dr Stephanie Lael Stauffer |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 200 Hawkins Dr, Iowa City, Iowa |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609160548 | NPI | - | NPPES |
Entity Name | State University Of Iowa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
The Department of Veterans Affairs will formally allow patients treated at its hospitals and clinics to use medical marijuana in states where it is legal, a policy clarification that veterans have sought for several years. A department directive, expected to take effect next week, resolves the conflict in veterans facilities between federal law, which outlaws marijuana, and the 14 states that allow medicinal use of the drug, effectively deferring to the states. ...Under department rules, veterans can be denied pain medications if they are found to be using illegal drugs.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCottonĀ® products in China, today announced that it was honored to receive the Shenzhen Baoan District Quality Award from the Market Supervision Administration of Shenzhen Municipality.
The Retina Implant developed by German medical technology company IIP Technologies, which is designed to restore a degree of sight to blind people suffering from certain retinal degenerations, has successfully been put through a clinical test.
Although sucrose significantly reduces the pain experienced by preterm neonates undergoing heel lance, it is associated with significant increases in adenosine triphosphate use and oxidative stress, the results of a US study indicate.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that it has initiated its Phase II trial of XIAFLEX (collagenase clostridium histolyticum) for the treatment of human lipoma.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephanie Lael Stauffer, MD 200 Hawkins Dr, Department Of Pathology, Iowa City, IA 52242-1009 Ph: () - | Dr Stephanie Lael Stauffer, MD 200 Hawkins Dr, Department Of Pathology, Iowa City, IA 52242-1009 Ph: (319) 356-1616 |
News Archive
The Department of Veterans Affairs will formally allow patients treated at its hospitals and clinics to use medical marijuana in states where it is legal, a policy clarification that veterans have sought for several years. A department directive, expected to take effect next week, resolves the conflict in veterans facilities between federal law, which outlaws marijuana, and the 14 states that allow medicinal use of the drug, effectively deferring to the states. ...Under department rules, veterans can be denied pain medications if they are found to be using illegal drugs.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCottonĀ® products in China, today announced that it was honored to receive the Shenzhen Baoan District Quality Award from the Market Supervision Administration of Shenzhen Municipality.
The Retina Implant developed by German medical technology company IIP Technologies, which is designed to restore a degree of sight to blind people suffering from certain retinal degenerations, has successfully been put through a clinical test.
Although sucrose significantly reduces the pain experienced by preterm neonates undergoing heel lance, it is associated with significant increases in adenosine triphosphate use and oxidative stress, the results of a US study indicate.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that it has initiated its Phase II trial of XIAFLEX (collagenase clostridium histolyticum) for the treatment of human lipoma.
› Verified 8 days ago
Dr. John Phillip Lee, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Dept Of Pathology, Iowa City, IA 52242 Phone: 319-384-9605 Fax: 319-467-5193 | |
Dr. Carol Joy Holman, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-3981 Fax: 319-384-8051 | |
James A Goeken, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-1966 Fax: 319-384-8053 | |
Sergei I Syrbu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-7372 Fax: 319-384-8053 | |
Jo A Benda, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4436 Fax: 319-384-8052 | |
Amani Abdalla Bashir, MBBS Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Drive, University Of Iowa Hospitals And Clinics, Iowa City, IA 52242 Phone: 319-467-5706 Fax: 319-356-8470 | |
Mr. Paul J Belding, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 321 E Market St Ste 102, Iowa City, IA 52245 Phone: 319-337-7284 Fax: 319-337-7284 |